General Archive
-
Articles & blogs
Alzheimer’s drug lecanemab approved by US regulator
LifeArc’s Chief Scientific Officer Dr Dave Powell comments on news that lecanemab has received regulatory and safety approval from the…
-
News releases
Evolving our science to solve complex healthcare challenges
Dave Powell on why LifeArc is evolving the way we do our science – and the difference we hope it…
-
Articles & blogs
2022 wrapped – our highlights from a pivotal year
We’ve seen some exciting scientific progress, forged new partnerships and launched some new landmark initiatives.
-
News releases
LifeArc partners with EMBARC to improve healthcare for people living with bronchiectasis
Three-year partnership to improve healthcare for thousands of people across Europe living with bronchiectasis.
-
Articles & blogs
MND Collaborative Partnership cautiously welcomes new Government funding
We cautiously welcome the Government’s announcement on how their £50m commitment into MND research will be spent.
-
Articles & blogs
Repurposed flu medicine could help under 60s recover faster from COVID-19
Results of an international repurposing study show favipiravir could help with COVID-19.
-
Articles & blogs
LifeArc bolsters executive team with communications expertise
Welcome to Anna Tomlinson, who joins LifeArc as our first Chief Communications Officer.
-
News releases
LifeArc announces £10m funding call for new chronic respiratory infection therapies
First major funding call announced as part of our £100m Chronic Respiratory Infection Translational Challenge
-
News releases
£100m programme to transform care for people living with chronic lung conditions
More than 300,000 people in the UK are living with bronchiectasis and more than 10,000 have been diagnosed with cystic…
-
News releases
LifeArc responds to the Government’s renewed pledge to increase R&D funding
LifeArc CEO Dr Melanie Lee welcomes the Government’s restatement of its commitment to increase R&D funding in today’s Autumn statement:…
-
Articles & blogs
LifeArc plays key role in discovery of new Alzheimer’s treatment
LifeArc played an important part in the discovery of lecanemab, an experimental drug that has shown some benefits for people…
-
News releases
LifeArc funds home monitoring trials for people with chronic respiratory conditions
Trials will examine the impact of home monitoring and machine learning decision support algorithms for people with CF and bronchiectasis.